Cite
Anti-arrhythmic drugs confer increased risks of bradyarrhythmia in patients undergoing direct current cardioversion for atrial fibrillation
MLA
Frederik Dalgaard, et al. “Anti-Arrhythmic Drugs Confer Increased Risks of Bradyarrhythmia in Patients Undergoing Direct Current Cardioversion for Atrial Fibrillation.” European Heart Journal, vol. 41, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........120bc3dcccb4b98c9d93d9882ac142c5&authtype=sso&custid=ns315887.
APA
Frederik Dalgaard, Torp-Pedersen Ct, Jannik Langtved Pallisgaard, M. H. Ruwald, Morten Lock Hansen, Peter Vestergaard Rasmussen, & G. H. Gislason. (2020). Anti-arrhythmic drugs confer increased risks of bradyarrhythmia in patients undergoing direct current cardioversion for atrial fibrillation. European Heart Journal, 41.
Chicago
Frederik Dalgaard, Torp-Pedersen Ct, Jannik Langtved Pallisgaard, M. H. Ruwald, Morten Lock Hansen, Peter Vestergaard Rasmussen, and G. H. Gislason. 2020. “Anti-Arrhythmic Drugs Confer Increased Risks of Bradyarrhythmia in Patients Undergoing Direct Current Cardioversion for Atrial Fibrillation.” European Heart Journal 41 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........120bc3dcccb4b98c9d93d9882ac142c5&authtype=sso&custid=ns315887.